Chemoinformaics analysis of 3-(6,6-DIMETHYL-5-OXOHEPT-2-ENYL)-CYCLOHEXANONE
| Molecular Weight | 236.355 | nRot | 4 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 9 |
| Exact Molecular Weight | 236.178 | nRing | 1 |
| Solubility: LogS | -2.878 | nHRing | 0 |
| Solubility: LogP | 2.841 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 42.657 |
| nHD | 0 | BPOL | 25.813 |
| QED | 0.697 |
| Synth | 3.205 |
| Natural Product Likeliness | 1.12 |
| NR-PPAR-gamma | 0.834 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.981 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.616 |
| MDCK | 0.0000199 |
| BBB | 0.984 |
| PPB | 0.889641 |
| VDSS | 0.838 |
| FU | 0.0984927 |
| CYP1A2-inh | 0.197 |
| CYP1A2-sub | 0.884 |
| CYP2c19-inh | 0.272 |
| CYP2c19-sub | 0.793 |
| CYP2c9-inh | 0.293 |
| CYP2c9-sub | 0.481 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.392 |
| CYP3a4-inh | 0.16 |
| CYP3a4-sub | 0.47 |
| CL | 4.2 |
| T12 | 0.79 |
| hERG | 0.021 |
| Ames | 0.023 |
| ROA | 0.013 |
| SkinSen | 0.943 |
| Carcinogencity | 0.621 |
| EI | 0.832 |
| Respiratory | 0.863 |
| NR-Aromatase | 0.026 |
| Antiviral | Yes |
| Prediction | 0.832232 |